TW201029831A - Processor controlled ophthalmic device - Google Patents
Processor controlled ophthalmic device Download PDFInfo
- Publication number
- TW201029831A TW201029831A TW098136787A TW98136787A TW201029831A TW 201029831 A TW201029831 A TW 201029831A TW 098136787 A TW098136787 A TW 098136787A TW 98136787 A TW98136787 A TW 98136787A TW 201029831 A TW201029831 A TW 201029831A
- Authority
- TW
- Taiwan
- Prior art keywords
- data processor
- lens
- insert
- mold
- mold part
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 27
- 230000003287 optical effect Effects 0.000 claims description 27
- 239000000178 monomer Substances 0.000 claims description 19
- 230000008859 change Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 claims description 3
- 229910001416 lithium ion Inorganic materials 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims 2
- 238000013500 data storage Methods 0.000 claims 1
- 239000002159 nanocrystal Substances 0.000 claims 1
- 239000010409 thin film Substances 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 abstract description 4
- 229920001296 polysiloxane Polymers 0.000 abstract description 3
- -1 polyethylene Polymers 0.000 description 25
- 125000000524 functional group Chemical group 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- 125000000217 alkyl group Chemical group 0.000 description 16
- 125000004432 carbon atom Chemical group C* 0.000 description 15
- 238000004891 communication Methods 0.000 description 10
- 239000004743 Polypropylene Substances 0.000 description 9
- 238000012937 correction Methods 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 238000003860 storage Methods 0.000 description 8
- 229920001155 polypropylene Polymers 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000004065 semiconductor Substances 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 150000001412 amines Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000005499 meniscus Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005055 memory storage Effects 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 125000005702 oxyalkylene group Chemical group 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 125000005504 styryl group Chemical group 0.000 description 2
- 238000007514 turning Methods 0.000 description 2
- VAYTZRYEBVHVLE-UHFFFAOYSA-N 1,3-dioxol-2-one Chemical compound O=C1OC=CO1 VAYTZRYEBVHVLE-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical group COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- HOUUMBWACGHTGY-UHFFFAOYSA-N C(=C)OC(=O)SCCCC(C(OCCCCCCCCCCCCC)(OCCCCCCCCCCCCC)OCCCCCCCCCCCCC)CCCCCCCC Chemical compound C(=C)OC(=O)SCCCC(C(OCCCCCCCCCCCCC)(OCCCCCCCCCCCCC)OCCCCCCCCCCCCC)CCCCCCCC HOUUMBWACGHTGY-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000004593 Epoxy Chemical group 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- ODQUDRGGWYOGBJ-UHFFFAOYSA-N NN.C=C Chemical group NN.C=C ODQUDRGGWYOGBJ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 101100460147 Sarcophaga bullata NEMS gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 229920006109 alicyclic polymer Polymers 0.000 description 1
- 125000005157 alkyl carboxy group Chemical group 0.000 description 1
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 238000007516 diamond turning Methods 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004384 eye physiology Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- JDTXSWGCYBOHDZ-UHFFFAOYSA-N n-(9h-fluoren-1-yl)prop-2-enamide Chemical compound C1C2=CC=CC=C2C2=C1C(NC(=O)C=C)=CC=C2 JDTXSWGCYBOHDZ-UHFFFAOYSA-N 0.000 description 1
- SQDFHQJTAWCFIB-UHFFFAOYSA-N n-methylidenehydroxylamine Chemical compound ON=C SQDFHQJTAWCFIB-UHFFFAOYSA-N 0.000 description 1
- BHYJMUFNVQBDRC-UHFFFAOYSA-N n-sulfanylprop-2-enamide Chemical compound SNC(=O)C=C BHYJMUFNVQBDRC-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00028—Bifocal lenses; Multifocal lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/0074—Production of other optical elements not provided for in B29D11/00009- B29D11/0073
- B29D11/00807—Producing lenses combined with electronics, e.g. chips
- B29D11/00817—Producing electro-active lenses or lenses with energy receptors, e.g. batteries or antennas
- B29D11/00826—Producing electro-active lenses or lenses with energy receptors, e.g. batteries or antennas with energy receptors for wireless energy transmission
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Computer Networks & Wireless Communication (AREA)
- Microelectronics & Electronic Packaging (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Eyeglasses (AREA)
- Prostheses (AREA)
- Casting Or Compression Moulding Of Plastics Or The Like (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Abstract
Description
201029831 六、發明說明: 【相關申請案之交互引用】 本發明主張美國專利臨時申請案u.s. Provisional Application No. 61 /11 〇,213的優先權,發明名稱是處理 器控制之眼科設備(Processor Controlled Ophthalmic Device) ’申請曰是2〇〇8年1〇月31曰,其内容為本 案之依據並納入本案。 ❿ 【發明所屬之技術領域】 本發明係描述包括資料處理裝置之眼科設備,尤 指製造含嵌入資料處理器及一個或多個組件之媒體嵌 件之眼科透鏡的方法。 【先前技術】 傳統上,如隱形眼鏡或人工水晶體(Intraocular Lens)等的眼科透鏡提供業已決定的光學特質。例如, 隱形眼鏡雖可提供—項❹項:視力矯正功能、加強 妝飾及治療效果’但财__組視鴻正舰。每種功 能係由-種透鏡的物理特性所提供。基本上,將折射 =質與透鏡結合岐計可提供視讀正舰。添加色 素的透鏡結合可提供加強妝飾效果。將活性劑與透鏡 結合可提供治療效果。 从迄今崎透鏡的絲特質在設計上已整合入透鏡 也『特性。—般而言,光學設計已於透鏡製造時確 的光學特質在其成形後即保持㈣不變。 201029831 者有時可能會察覺到若不只可使用一種焦度,對於調 節視力會更加有利。隱形眼鏡的配戴者或植入人工水 晶體的人與可更換眼鏡來修正光學的眼鏡配戴者不 同,若未耗費巨大心力,將無法變更其視力矯正之功 能特性。 【發明内容】 因此,本發明包括含資料處理器的眼科透鏡,該 資料處理器可有效變更眼科透鏡内的一個或多値組件 的狀態。組件之狀態變化可提供眼科透鏡其他功能。 此外,亦提出形成含資料處理器之眼科透鏡的方法與 裝置。一些一些實施例亦包括含剛性或可塑之能量化 嵌件的鑄模矽水膠(Silicone Hydrogel)隱形眼鏡,該能 量化嵌件額外包括資料處理器,其中嵌件以生物相容 之方式包含在眼科透鏡内。 一般而a,處理器與能量來源可被固定至或做為 媒體嵌件的一部份,且媒體嵌件會被放置於接近至少 一個第一個模具零件與第二個模具零件之處。活性單 體混合物(Reactive Monomer Mix)額外放置於第一個 模具零件與第二個模具零件之間。第一個模具零件被 放單於接近第二個模具零件之處,因而形成含能量化 媒體喪件之透鏡孔穴,且在透鏡孔穴内至少含一些活 性單體混合物;活性树混合物暴露於光化輻射下, 以形成眼科透鏡。魏騎過控㈣性賴混合物所 暴露之光化輻射形成。含資料處理器之媒舰件包含 在透鏡内。 201029831 【實施方式】 及裝ί發:括Ϊ造含資料處理器之眼科透鏡的方法 科透鏡之眼料鏡發财包括含將轉處理11加入眼201029831 VI. Description of the invention: [Reciprocal citation of related application] The present invention claims the priority of the US Patent Provisional Application No. 61 /11 〇, 213, the name of the invention is processor controlled ophthalmic equipment (Processor Controlled Ophthalmic) Device) 'Application 曰 is 2 〇〇 8 years 1 〇 31 曰, the content of which is the basis of the case and included in the case. FIELD OF THE INVENTION The present invention is directed to ophthalmic devices including data processing devices, and more particularly to methods of making ophthalmic lenses comprising a media insert embedded in a data processor and one or more components. [Prior Art] Traditionally, ophthalmic lenses such as contact lenses or intraocular lenses have provided optical properties that have been determined. For example, contact lenses can provide - items: vision correction, enhancement of makeup and treatment effects. Each function is provided by the physical properties of the lens. Basically, the combination of refraction = mass and lens can provide a visual read. A lens combination with added color provides enhanced finishing. Combining the active agent with a lens provides a therapeutic effect. The silk traits of the Saki lens have been integrated into the lens since the design. In general, optical design has been consistent with the optical properties of the lens when it is formed (4). 201029831 Sometimes you may notice that if you can use more than one power, it will be more beneficial to adjust your vision. The contact lens wearer or the person who implants the artificial crystal is different from the interchangeable glasses to correct the optical lens wearer. Without the great effort, the function of vision correction cannot be changed. SUMMARY OF THE INVENTION Accordingly, the present invention includes an ophthalmic lens containing a data processor that effectively changes the state of one or more components within the ophthalmic lens. Changes in the state of the component provide additional functionality to the ophthalmic lens. In addition, methods and apparatus for forming an ophthalmic lens containing a data processor are also proposed. Some embodiments also include a Silicone Hydrogel contact lens comprising a rigid or plasticized energy-inducing insert, the energy-increasing insert additionally comprising a data processor, wherein the insert is biocompatible in the ophthalmology Inside the lens. Typically, a, the processor and energy source can be fixed to or as part of the media insert, and the media inserts can be placed adjacent to at least one of the first mold part and the second mold part. A Reactive Monomer Mix is additionally placed between the first mold part and the second mold part. The first mold part is placed close to the second mold part, thus forming a lens cavity containing the energy media, and containing at least some active monomer mixture in the lens cavity; the active tree mixture is exposed to actinic Under radiation, to form an ophthalmic lens. Wei riding over (4) the formation of actinic radiation exposed by the mixture. The media carrier containing the data processor is contained within the lens. 201029831 [Embodiment] and installation: Ϊ Ϊ Ϊ Ϊ 含 含 含 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科 科
户會發明之詳細說明的章節會詳細描述。較 一實施例之說明僅為範例,且精於此項 々富可輕易思及各種變化、修改及變更。因 此該不範實施例並未限制基本發明之原理。 專門術語 在本發明之詳細說明以及申請專利範圍中,各種 的術語是以下列的說明定義: 資料處理器:此於本文内所述之詞係指接收數位 資料並根據接收之資料執行運算之一條電路或一串聯 電路。 能量化··此於本文内所述之詞係指可供應電流,或儲 存電能於其中之狀態。 能量··此於本文内所述之詞係指物理系統作工之 能力。許多上述術語於本發明内之使用係關於可以作 電功之能力。 , 能量來源:本文内所述之詞係指可供應能量或使 生醫設備進入能量化狀態之設備。 能量擷取器:此於本文内所述之詞係指可從環境 擷取能量並將擷取之能量轉換為電能之裝置。 5 201029831 透鏡:係指位於眼睛内或眼睛上之任何眼科設 備。這些設備可以提供視力矯正或妝飾作用。例如, 透鏡一詞可意指隱形眼鏡、人工水晶體、覆蓋透鏡 (overlay lens)、眼嵌入物(〇cular insert)、光學嵌入物 (optical insert)或其他可藉以矯正或修改視力,或在不 傷害視力的情況下可加強妝飾眼睛生理(例如虹膜顏 色)之設備。在一些實施例中,本發明較佳透鏡係以矽 橡膠或矽水膠製成之軟式隱形眼鏡,其中包括但不限 硬水膠及螢光水膠(Fluorohydrogels)。 成鏡混合物或「活性混合物」或rRMM」(活性 單體混合物):本文内所述之詞係指可固化並交聯以成形 眼科透鏡之單體或預聚合物材料。各種成鏡混合物之 實施例可包括含一種或多種如下所述之添加劑:uv阻 斷劑、染色、光起始劑或催化劑,以及其他可能在如 隱形眼鏡或人工水晶體等眼科透鏡内所需的添加劑。 成鏡表面:係指用於模造透鏡之表面。在一些實 施例中’任何此類表面103-104可具有光學特質表面 光度’此表示其平滑與成形程度足以使,藉由與模面 接觸之成鏡材料聚合作用方式製造的鏡面在光學特性 上可被接受。而且,在一些實施例中,成鏡表面103-104 可具有必須授予鏡面所需光學特質之幾何,其中包括 但不限於球面、非球面及圓柱折射力(Cylinder Power)、波前誤差矯正、角膜地形圖矯正(c〇rneal Topography Correction ),以及相似之物及其任何级合。 201029831 鋰離子電池:係指電化電池,其中鋰離子穿越過 池以產生電能。此電化電池一般稱為電池,可在其 標準型齡转通上電流或充電。 媒件:此於本文内所述之詞係指可維持眼科 中兄内敗*量來源之可塑或剛性基板。在一些實施例 媒體嵌件亦可包括一個或多個可變光學透鏡。 模具.係指可用於以未固化配方成形透鏡之剛性 剛性物體。—純佳模具包括成形前曲面模具零 件/、後曲面模具零件的兩個模型零件。The detailed description of the invention will be described in detail. The description of the embodiment is merely an example, and it is obvious that the various changes, modifications and changes can be easily considered. Therefore, the exemplary embodiment does not limit the principles of the basic invention. Terminology In the detailed description of the invention and in the scope of the claims, various terms are defined by the following description: Data processor: The term as used herein refers to receiving a digital data and performing an operation based on the received data. Circuit or a series circuit. Energyization · The term as used herein refers to a state in which current can be supplied or stored in it. Energy · The term described herein refers to the ability of a physical system to work. The use of many of the above terms in the present invention relates to the ability to perform electrical work. , Energy Source: The term described in this document refers to equipment that supplies energy or allows a medical device to enter an energized state. Energy picker: As used herein, the term refers to a device that extracts energy from the environment and converts the extracted energy into electrical energy. 5 201029831 Lens: Any ophthalmic device located in or on the eye. These devices can provide vision correction or makeup. For example, the term lens may mean a contact lens, an artificial lens, an overlay lens, an insertcular insert, an optical insert or the like to correct or modify vision, or not to harm Equipment that enhances eye physiology (such as iris color) in the case of vision. In some embodiments, preferred lenses of the present invention are soft contact lenses made of silicone rubber or hydrophobic glue, including but not limited to hard water gels and Fluorohydrogels. Mirrored mixture or "active mixture" or rRMM" (active monomer mixture): As used herein, the term refers to a monomer or prepolymer material that is curable and crosslinkable to form an ophthalmic lens. Examples of various mirror-forming mixtures may include one or more additives as described below: uv blockers, dyes, photoinitiators or catalysts, as well as other possibilities that may be required in ophthalmic lenses such as contact lenses or artificial crystals. additive. Mirrored surface: refers to the surface used to mold the lens. In some embodiments 'any such surface 103-104 may have an optical characteristic surface luminosity' which means that it is smooth and shaped to a sufficient extent that the mirror surface produced by the structuring of the mirror material in contact with the die face is optically Can be accepted. Moreover, in some embodiments, the mirrored surfaces 103-104 may have geometry that must impart the desired optical properties to the mirror, including but not limited to spherical, aspherical, and cylindrical refractive power, wavefront error correction, cornea Topographic correction (c〇rneal Topography Correction), and similar objects and any of their combinations. 201029831 Lithium-ion battery: refers to an electrochemical battery in which lithium ions pass through a cell to generate electricity. This electrochemical battery is generally called a battery and can be currented or charged during its standard age. Media: The term described herein refers to a plastic or rigid substrate that maintains a source of loss in the eye. In some embodiments the media insert may also include one or more variable optical lenses. Mold. A rigid, rigid object that can be used to shape a lens in an uncured formulation. — Pure molds include two model parts for forming front surface mold parts/back surface mold parts.
光學區:此於本文内所述之詞係指眼科透鏡配戴者 看穿過眼科透鏡之區域。 功率.此於本文内所述之詞係指每時間單位之作 功或傳遞之能量。 ^可充電或可重新通上電流:此於本文内所述之詞 係指恢復至可作工之更高容量狀態的能力 。許多上述 術m=本發明内之使用可能與恢復之能力有關 ,該恢 y之忐力係以使電流在一特定重建之期間内以特定速 率流動之能力來恢復。 重新通上電流或充電:恢復至可作工之更高容量 狀態。許多上述術語於本發_之❹可能與設備之 敗復有關’該琢備之恢復係讓設備恢復至具有使電流 在-特定重建之期間内以特定速率流動之能力。 一自模具釋放:係指透鏡已自模具完全分離,或僅 固定’因此_搖動即可取出透鏡,或使用拭子 (Swab)推出。 7 201029831 请參閱圖1,含散入式資料處理器ill之眼科透鏡 100亦可包括能量來源109 ’例如電化電池或作為能量 儲存裝置的電池,且在一些實施例中,會封裝或隔離 包含有來自環境之能量來源的材料,且眼科透鏡亦會 放置於該材料内。能量來源109可提供啟動資料處理 器之功率。 用於眼睛透鏡之範例總成模具100之圖示顯示資 料處理器111。模具包括具有孔穴105之總成模具 100;成鏡混合物可分配至孔穴105内,以成鏡混合物 發生化學反應或固化後’即產生所需形狀的眼科透 鏡。本發明之模具及模具總成係由不只一個「模具零 件」或「模具工件」101-102所製成。模具零件101_1〇2 可加以結合,使孔穴105於模具零件ι〇ι_ι〇2之間成 形’且透鏡可於該等模具零件之孔穴内成形。模具零 件10M02較佳為僅暫時結合。在透鏡成形之後,即 可再度分離模具零件10M02以卸下透鏡。 至少一模具零件101-102之表面103-104具有至 少一與成鏡混合物接觸的部份,以在成鏡混合物發生 化學反應或固化後,表面103-104即可提供所需之形 狀與形狀給與其接觸之透鏡的部份。至少一其他模具 零件10M02亦具有相同的方式。 因此’例如’在較佳實施例中,模組總成10〇以 兩個零件101-102形成;此兩個零件為母凹面工件(前 工件)102與公凸面工件(背工件)1〇1及在這兩個工件 之間形成之孔穴。與成鏡混合物接觸之凹面1〇4部分 具有將於模具總成1〇〇内製造之眼科透鏡前曲面的曲 201029831 率’且其平滑與成形程度足以使,藉由與凹面104接 觸之成鏡材料聚合作用方式製造的眼科透鏡表面在光 學特性上可被接受。 成鏡表面包括含光學特質表面光度之表面 103-104,此表示其平滑與成形程度足以使,藉由輿模 面接觸之成鏡材料聚合作用方式製造的鏡面在光學特 性上可被接受。而且,在一些實施例中,成鏡表面 103-104可具有必須授予鏡面所需光學特質之幾何,其 ❹ 中包括但不限於球面、非球面及圓柱折射力(CylinderOptical zone: As used herein, the term refers to the area in which the ophthalmic lens wearer sees through the ophthalmic lens. Power. The term "text" as used herein refers to the energy or energy delivered per unit of time. ^ Rechargeable or re-currentable: This term is used herein to refer to the ability to return to a higher capacity state in which it can be used. Many of the above-described operations of the present invention may be related to the ability to recover, which is to restore the ability of the current to flow at a particular rate during a particular reconstruction period. Reconnect current or charge: return to a higher capacity state where work is possible. Many of the above terms may be related to the failure of the device. The recovery of the device restores the device to the ability to cause current to flow at a particular rate during the particular reconstruction period. A release from the mold means that the lens has been completely separated from the mold, or only fixed so that the lens can be removed by shaking or by using a swab. 7 201029831 Referring to FIG. 1, an ophthalmic lens 100 including a data processor ill may also include an energy source 109' such as an electrochemical cell or a battery as an energy storage device, and in some embodiments, may be packaged or isolated. Materials from environmental sources of energy, and ophthalmic lenses are also placed in the material. Energy source 109 provides the power to activate the data processor. The illustration of the example assembly mold 100 for the eye lens displays the data processor 111. The mold includes an assembly die 100 having apertures 105; the mirrored mixture can be dispensed into the apertures 105 to form a desired mixture of ophthalmic lenses after the chemical mixture has been chemically reacted or cured. The mold and mold assembly of the present invention is made from more than one "mold part" or "mold workpiece" 101-102. The mold parts 101_1〇2 can be combined to form the holes 105 between the mold parts ι〇ι_ι 2 and the lenses can be formed in the cavities of the mold parts. The mold part 10M02 is preferably only temporarily bonded. After the lens is formed, the mold part 10M02 can be separated again to remove the lens. The surfaces 103-104 of at least one of the mold parts 101-102 have at least one portion in contact with the mirrored mixture to provide the desired shape and shape after the chemical reaction or solidification of the mirrored mixture. The part of the lens that comes into contact with it. At least one other mold part 10M02 also has the same manner. Thus, for example, in the preferred embodiment, the module assembly 10 is formed from two parts 101-102; the two parts are a female concave workpiece (front workpiece) 102 and a male convex workpiece (back workpiece) 1〇1 And a hole formed between the two workpieces. The portion of the concavity 1〇4 that is in contact with the mirrored mixture has a curvature of the front surface of the ophthalmic lens that is to be fabricated in the mold assembly, and the smoothness and shape are sufficient to form a mirror by contact with the concave surface 104. The ophthalmic lens surface produced by the material polymerization mode is optically acceptable. The mirrored surface comprises surfaces 103-104 containing optical luminosity surface luminosity, which means that it is smooth and shaped to a sufficient extent that the mirror surface produced by the morphological material contact of the stencil contact is optically acceptable. Moreover, in some embodiments, the mirrored surfaces 103-104 may have a geometry that must impart the desired optical properties to the mirror surface, including but not limited to spherical, aspherical, and cylindrical refractive power (Cylinder).
Power)、波前誤差矯正、角膜地形圖矯正(c〇meal Topography Correction)’以及相似之物及其任何組 合。根據本發明,光學特性可與資料處理器m共同 提供整體的光學特質。 資料處理器可在眼科透鏡的限制内提供資料操控 功能。在一些實施例中,資料操控可包括在接受到資 料後立即產生之一組或多組指令。在一些實施例中, ⑩ 接收之資料可以是接近透鏡之狀況指示,例如:透鏡 所暴露之水伤含1、透鏡表面溫度、包含在透鏡内之 電潤濕設備的狀態,或其他狀況。 其他實施例可能包括包含在透鏡内之組件狀態, . 例如用於紀錄組件供電或組件收到之輸入時間之計數 器的狀態。例如,接收之輸入可包括電磁脈衝、光圖 案、無線電頻率訊號’或其他資料通訊形式。 一些其他實施例亦可包括發出命令改變眼科透鏡 内液態凹凸透鏡部分之狀態的資料處理器;其中 201029831 之變化會使透鏡之光學特質產 液態凹凸透鏡部份108 生變化。 的生之指令可包括控制包含在眼科透鏡内之組件 益p;二或ί傳送來自眼科透鏡之資料的命令。根據 二^性之鮮],控制包含在眼科透鏡内之組件的命 7β L括·接收外部訊號以啟動包含在眼科透鏡内之 Γ或多個組件的狀輪詢週期。為改善-些組件之 政,’例如磁感應_或作為啟動開關之光感器,處Power), wavefront error correction, c〇meal topography correction (and 〇meal Topography Correction) and similar and any combination thereof. In accordance with the present invention, optical characteristics can be combined with data processor m to provide overall optical characteristics. The data processor provides data manipulation within the limits of the ophthalmic lens. In some embodiments, data manipulation can include generating one or more sets of instructions as soon as the data is received. In some embodiments, 10 the received data may be an indication of the condition of the proximity lens, such as: the water damage exposed by the lens, the lens surface temperature, the state of the electrowetting device contained within the lens, or other conditions. Other embodiments may include the state of the component contained within the lens, such as the state of the counter used to record the component's power supply or the input time received by the component. For example, the received input may include an electromagnetic pulse, a light pattern, a radio frequency signal' or other form of data communication. Some other embodiments may also include a data processor that issues commands to change the state of the liquid meniscus lens portion of the ophthalmic lens; wherein a change in 201029831 causes the optical characteristics of the lens to produce a change in the liquid meniscus lens portion 108. The instructions for the birth may include controlling the components contained in the ophthalmic lens; or the command to transmit the data from the ophthalmic lens. According to the succinctness, the component of the component contained in the ophthalmic lens is controlled to receive an external signal to initiate a polling cycle of the component or components contained in the ophthalmic lens. In order to improve the management of some components, such as magnetic induction _ or as a light sensor for the start switch,
理器可編成讓組件以特定之間隔開啟。依此方式,例 2 ’磁感應開關每一分鐘的時間可僅消耗能量10秒(或 一些其他間隔)<»其他實施例可讓f料處理器接收來自 感應透鏡溫度、透鏡表祕力、透鏡上_力之組件 的輸入,或可由電子、電磁或MEM設備可量測之其 他參數的輸入。 八The processor can be programmed to have the components open at specific intervals. In this way, Example 2 'magnetic induction switch can consume only 10 seconds of energy per minute (or some other interval). Other embodiments allow the f-processor to receive temperature from the sensing lens, lens surface, lens Input of components of the upper force, or other parameters that can be measured by electronic, electromagnetic or MEMS devices. Eight
根據無限制性之範例,資料處理器U1可包括超 低功率微控制器16位元或32位元RISC混合訊號處 理器。較佳為資料處理器經過封裝,例如氣密封裝於 陶瓷或其他不透水之材料。較佳之耗電量應為低乾 電,例如 250 mciro amps/MIPS active。一項範例包括According to an unrestricted example, data processor U1 may include an ultra low power microcontroller 16-bit or 32-bit RISC mixed-signal processor. Preferably, the data processor is packaged, such as hermetically sealed in a ceramic or other water impermeable material. The preferred power consumption should be low dry power, such as 250 mciro amps/MIPS active. An example includes
Texas Instruments MSP 430 微處理器。 在一些其他實施例中,資料處理器可發出控制變 焦透鏡之命令。該控制可讓電流穿過兩條或數條透明 邊界’該邊界一般為平行劃定包含兩種不互溶液體之 内部容積。此兩種不互溶之液體將具有不同的光學指 數。彈性元件之放置方式將使該元件反應液體壓力改 變而變形。液體壓力則會隨著資料處理器之指令所造 10 201029831 成的電荷改變而發生變化,該電荷係置於橫越一種或 兩種液體。 在-些實施例中,資料處理器控制之可變透鏡可 包括液態凹凸透鏡’其中包括含用以保留兩種或數種 液體量之電池的液體。非平面之下表面包括ddta軸 (axis delta)的圓錐狀或圓柱狀凹陷或凹處,其中包含一 滴絕緣液體。電池_物包括導電賴,额= 體互不溶且具有不同的折射指數,且在一些實施^中 ❿ I有相似或相同之密度。朝凹翻σ的職電極放置 於下盤的後面。另-電極則放置於與導電液體接觸。 藉由對電極施以電壓的方式,產生電潤濕作用,並以 電極間之施加的電壓(V)修改兩#液體之間介面的曲 率。通過與上盤和下盤垂直且在該滴絕緣液體區域内 之電池的光束將根據對電極所施加之電壓以更大或更 小的程度聚焦。導電液體-般為水性液體,而絕緣液 體一般則為油性液體。 ❹ 使用者控制之調整設備可用於與資料處理器介 接’因此可控制透鏡之焦距。根據無限制性之範例, 调整裝置可包括磁啟動開關、光啟動開關、感應眼睛 内讯號以對焦之電感應器、無線電頻率傳輸裝置,或 任何其他提供使用者規定之指令給處理器之電子設備 或被動設備。 在一些實施例中,含資料處理器lu的透鏡放置 於媒體上,該媒體包括剛心軟裙部設計(Rigid Center SoftSkirt Design),其中包括資料處理器U1之中心剛 性光學元件之前面表面與後面表面各自直接與大氣及 201029831 角膜表面接觸,其中透鏡材料之軟裙部(一般為水膠材 料)固定於剛性光學元件的周圍,且剛性光學元件亦作 為提供能量與功能給眼鏡透鏡之媒體嵌件。 一些其他實施例包括放置於媒體嵌件内之資料處 理器111,該媒體嵌件包括以水膠基材(Hydrogel Matrix)完全封裝之剛性或可塑透鏡嵌件。例如,剛性 或可塑透鏡嵌件可使用微射出成形技術製造。 例如,微射出成形實施例可包括直徑約介於6 mm 至10 mm且前表面半徑介於約6 mm至10 mm之間和 後表面半徑介於約6 mm至10 mm之間,以及中心厚 度介於0.050 mm與0.5 mm之間的聚4甲基1戊稀共 聚樹脂(poly(4-methylpent-l_ene copolymer resin)。一些 範例實施例包括直徑約為8.9 mm且前表面半徑約7.9 mm和後表面半徑約7.8 mm,以及中心厚度介於0.100 mm與邊緣輪廓約0.050 mm半徑之嵌件。一種範例微 成形機器可包括由Battenfield Inc.提供之Microsystem 50五嘲重系統。 放置於媒體嵌件上或内之資料處理器1U可放置 於用於形成眼科透鏡之模具零件10M02内。例如, 模具零件101-102材料可包括:一或數種的聚烯烴: ^^丙轉、聚本乙稀、^^乙稀、聚曱基丙稀酸曱醋,以 及改質聚烯基。其他模具可包括陶瓷或金屬材料。 較佳之脂環共聚物包含兩種不同的脂環聚合物, 且由Zeon Chemicals L.P.公司以ZEONOR商名販賣。 ZEONOR共有數種不同的等級。各種不同的等級可能 201029831 有從105°C至160°C的玻璃轉換溫度。特定較佳之材料 為 ZEONOR 1060R。 例如,其他可能與一種或數種添加劑結合以形成 眼科透鏡之模具材料包括Zieglar-Natta聚丙烯樹脂(有 時稱為znPP)。根據範例,Zieglar-Natta聚丙烯樹脂之 販售名稱為PP 9544 MED。PP 9544 MED係由 ExxonMobile Chemical Company 根據 FDA 法規 21 CFR (c) 3.2製造之用於清潔成形的淨化隨機共聚物。 ❹ PP 9544 MED係含亞甲基之隨機聚合物(znpP)(以下 簡稱9M4 MED)。其他範例Zieglar-Natta聚丙烯樹脂 包括:Atofina Polypropylene 3761 # AtofinaTexas Instruments MSP 430 microprocessor. In some other embodiments, the data processor can issue commands to control the zoom lens. This control allows current to pass through two or more transparent boundaries. The boundary is generally parallel to define an internal volume containing two immiscible liquids. These two immiscible liquids will have different optical indices. The placement of the elastic element will cause the element to change in response to changes in fluid pressure. The liquid pressure changes as the charge changes from the data processor's instructions 10 201029831, which is placed across one or both liquids. In some embodiments, the data processor controlled variable lens may comprise a liquid meniscus lens' which includes a liquid containing a battery for retaining two or more amounts of liquid. The non-planar lower surface includes a conical or cylindrical depression or recess of the ddta axis (axis delta) containing a drop of insulating liquid. The battery _ includes conductive ray, the amount = body is insoluble and has different refractive indices, and in some implementations ❿ I have similar or identical density. The electrode facing the concave σ is placed behind the lower plate. The other electrode is placed in contact with a conductive liquid. Electrowetting is generated by applying a voltage to the electrodes, and the curvature of the interface between the two liquids is modified by the applied voltage (V) between the electrodes. The beam passing through the cell perpendicular to the upper and lower discs and in the region of the drop of insulating liquid will be focused to a greater or lesser extent depending on the voltage applied to the counter electrode. Conductive liquids are generally aqueous liquids, while insulating liquids are generally oily liquids.使用者 User-controlled adjustment devices can be used to interface with the data processor' so that the focal length of the lens can be controlled. According to an unrestricted example, the adjustment device may include a magnetic start switch, an optical start switch, an electrical sensor that senses an eye signal to focus, a radio frequency transmission device, or any other electronic device that provides a user-specified command to the processor. Equipment or passive equipment. In some embodiments, the lens containing the data processor lu is placed on a medium comprising a Rigid Center SoftSkirt Design including the front and back surfaces of the central rigid optical element of the data processor U1. Each is in direct contact with the atmosphere and the 201029831 corneal surface, wherein the soft skirt of the lens material (typically a hydrocolloid material) is secured around the rigid optical element, and the rigid optical element acts as a media insert that provides energy and functionality to the spectacle lens. Some other embodiments include a data processor 111 placed within a media insert that includes a rigid or moldable lens insert that is fully encapsulated with a Hydrogel Matrix. For example, rigid or moldable lens inserts can be fabricated using micro-injection molding techniques. For example, the micro-extrusion forming embodiment can include a diameter of between about 6 mm and 10 mm and a front surface radius of between about 6 mm and 10 mm and a back surface radius of between about 6 mm and 10 mm, and a central thickness. Poly(4-methylpent-l_ene copolymer resin) between 0.050 mm and 0.5 mm. Some example embodiments include a diameter of about 8.9 mm and a front surface radius of about 7.9 mm and An insert with a surface radius of approximately 7.8 mm and a center thickness of 0.100 mm and an edge profile of approximately 0.050 mm radius. An exemplary microforming machine may include a Microsystem 50 five-story system from Battenfield Inc. placed on a media insert. Or the data processor 1U may be placed in the mold part 10M02 for forming an ophthalmic lens. For example, the mold part 101-102 material may include: one or several kinds of polyolefins: ^^-propene, polyethylene, ^^ Ethylene, polydecyl acrylate vinegar, and modified polyalkenyl. Other molds may include ceramic or metal materials. Preferred alicyclic copolymers contain two different alicyclic polymers, and by Zeon Chemicals LP company to ZEONOR business There are several different grades for ZEONOR. Various grades may have a glass transition temperature from 105 ° C to 160 ° C for 201029831. A particularly preferred material is ZEONOR 1060R. For example, other combinations may be combined with one or several additives. The mold material for forming the ophthalmic lens includes Zieglar-Natta polypropylene resin (sometimes referred to as znPP). According to the example, the Zieglar-Natta polypropylene resin is sold under the name PP 9544 MED. The PP 9544 MED is manufactured by ExxonMobile Chemical Company under FDA regulations. 21 CFR (c) 3.2 Purified random copolymers for cleansing. ❹ PP 9544 MED is a methylene-containing random polymer (znpP) (hereinafter referred to as 9M4 MED). Other examples include Zieglar-Natta polypropylene resin. :Atofina Polypropylene 3761 # Atofina
Polypropylene 3620WZ ° 而且,在一些實施例中,本發明之模具可能包括 如聚丙烯、聚乙烯、聚苯乙烯、聚曱基丙烯酸曱酯、 在主鏈内含脂環部分之改質聚烯烴,以及環聚烯煙。 此摻合物可在一個或兩個半邊模具上使用,其中較佳 φ 的方式則是將此掺合物用於背曲面,且前曲面由脂環 共聚物組成。 在一些根據本發明製作模具100之較佳方法中, 係根據已知技術使用射出成形,然而,實施例亦可包 括以其他技術製造之模具,例如:車削、鑽石車削或 雷射切割β 一般而言,透鏡在模具零件101-102之至少一表 面上成形。然而,在一些實施例中,透鏡之一表面可 從模具零件10Μ02成形,且另一透鏡表面可使用車 削方法或其他方法成形。 201029831 透鏡 明參閱圖2,圖中包括含資料處理器2〇4之媒體 後件201 #激活已啟動眼科透鏡2〇〇所具有之元件。 如圖所示’媒體嵌件2〇1嵌入於水膠透鏡材料207内。 啟動器205可用於執行包含在處理器2〇4内記憶儲存 裝置内之一項或數項可執行之程式。在一些實施例 中,透過處理器執行之程式可讓組件203的狀態變 化。記憶儲存裝置可包括隨機隨存記憶半導體、唯讀 記憶半導體、靜態記憶體、可抹除式可程式化唯讀記 憶體,或其他可儲存數位資料並提供命令資料之其他 組件。 如光感器202等的能量擷取器可包含在内,以充 電忐量來源208 (例如鐘離子電池或電容器)。資料處 理器204可用於管理重新通電之流程。例如,處理器 可接收存在於能量來源208内電荷量之資料指示,並 開啟電路,使電流可從能量擷取器202流動至能量來 源208。在另一態樣,其他處理器亦可編程監視何時 能量擷取器202可提供充足之電流來為能量來源2〇8 充電’並透過電路提供適合此類充電之電路徑。例如, 充電之電路可包括做為開關之用的電晶體,以及確保 電流流動方向正確的二極體 請參閱圖7。圖中係為本發明一些實施例之透視 圖。此透視圖為能量擷取器701與能量來源702之實 施例’每項設備皆透過導電電路路徑706與資料處理 器704進行電通訊。其它組件7〇7可為各種半導體、 201029831 固態、主動或被動設備,其可成為包含在媒體嵌件内 之電路的一部分。在一些實施例中,電路路徑706、 組件707、能量擷取器701、能量來源702及資料處理 器704、感應器及其他設備可安裝在可撓性基板7〇5 上0 液態凹凸透鏡-Polypropylene 3620WZ ° Moreover, in some embodiments, the mold of the present invention may include, for example, polypropylene, polyethylene, polystyrene, polydecyl methacrylate, modified polyolefin having an alicyclic moiety in the main chain, and Cyclic olefin smoke. The blend can be used on one or two half-side molds, with the preferred φ being the blend for the back curve and the front curve consisting of the alicyclic copolymer. In some preferred methods of making mold 100 in accordance with the present invention, injection molding is used in accordance with known techniques, however, embodiments may also include molds made by other techniques, such as turning, diamond turning, or laser cutting. The lens is formed on at least one surface of the mold parts 101-102. However, in some embodiments, one surface of the lens may be formed from the mold part 10Μ02, and the other lens surface may be formed using a turning method or other methods. 201029831 Lens See Figure 2, which includes the media containing the data processor 2〇4. The back piece 201 #activates the components of the activated ophthalmic lens 2〇〇. The media insert 2〇1 is embedded in the hydrofoam lens material 207 as shown. The launcher 205 can be configured to execute one or more executable programs contained within the memory storage device of the processor 2〇4. In some embodiments, the program executed by the processor can cause the state of component 203 to change. Memory storage devices may include random memory semiconductors, read-only memory semiconductors, static memory, erasable programmable read-only memory, or other components that store digital data and provide command material. An energy extractor such as photosensor 202 can be included to charge the source 208 (e.g., a clock ion battery or capacitor). The data processor 204 can be used to manage the re-energization process. For example, the processor can receive an indication of the amount of charge present in the energy source 208 and turn on the circuit such that current can flow from the energy extractor 202 to the energy source 208. In another aspect, other processors are also programmable to monitor when the energy harvester 202 can provide sufficient current to charge the energy source 2〇8 and provide an electrical path through the circuit suitable for such charging. For example, the charging circuit can include a transistor for the switch and a diode to ensure that the current flows in the correct direction. See Figure 7. The drawings are perspective views of some embodiments of the invention. This perspective is an embodiment of energy picker 701 and energy source 702. Each device is in electrical communication with data processor 704 via conductive circuit path 706. The other components 7〇7 can be various semiconductors, 201029831 solid state, active or passive devices that can be part of the circuitry contained within the media insert. In some embodiments, circuit path 706, component 707, energy extractor 701, energy source 702 and data processor 704, inductors, and other devices can be mounted on flexible substrate 7〇5.
在一些實施例中,一種較佳透鏡材料包括一含3 石夕氧組分。「-含㈣氧組分」是在單體、大分子 或預聚物中至少包含—[1〇-]單元。較佳 人 石夕氧組分中存在的總抑子和接上的氧料量^ 聚碎氧組分總分子量超過2G重量 η 30重量百分比。有用的含 更佳為超a 合的官能基,例如㈣酸、較佳為包括可為 甲基丙烯醯胺、乙烯基、土丙烯酸、丙烯醯胺、 胺以及苯乙烯基官能基。乙烯基内®^胺、Ν-乙烯画 包括分子式1化^物之合適含聚石夕氧組分 R1 R1-Si- R1 R1. R1 R1 〇-Si-Ri R1In some embodiments, a preferred lens material comprises a 3 oxalate containing component. The "-(IV)-containing oxygen component" contains at least a -[1〇-] unit in a monomer, a macromolecule or a prepolymer. Preferably, the total amount of the total amount of the total amount of the oxygen and the amount of the oxygen-containing oxygen component present in the component of the compound is more than 2G by weight η 30% by weight. Useful include functional groups which are more preferably supera, such as (tetra) acid, preferably including methacrylamide, vinyl, earth acrylic acid, acrylamide, amine, and styryl functional groups. Vinyl inner amine, hydrazine-ethylene painting, including the poly-stone component of the formula 1 R1 R1-Si- R1 R1. R1 R1 〇-Si-Ri R1
b R 其中 R1係個別從 香族烴基選出的 201029831 基、氨基、雜環含氧基、羧基、烷基羧基、烷氧基、 含胺基、氨基甲酸、碳酸、齒素或者其組合選出之官 能基;且包括1至100個Si-Ο重複單元的單價矽氧烷 鏈可更進一步從烷基、氫氧基、氨基、雜環含氧基、 竣基、烧基致基、烧氧基、含胺基、敦基甲酸、鹵素 或者其組合選出之官能基; 其中b = 0至500,應理解當b不等於0時,則b 為具有等同於一指定值模式的分佈; 其中至少一 R1包括單價反應官能基,且在一些實 施例中介於一至3個R1包括單價反應官能基。 如本文所述,在此所使用的「單價反應官能基」 為能夠進行自由基和/或陽離子聚合反應的官能基。非 限定的自由基反應官能基例子包括(甲基)丙烯酸、苯 乙烯基、乙烯基、乙烯醚、Ck烷基(甲基)丙烯酸、(曱 基)丙烯醯胺、Ck烷基(曱基)丙烯醯胺、N-乙烯醯胺, N-乙烯内醯胺、(:2_12亞烷基、C2_12亞烷基苯基、C2-12 亞烷基萘基、C2_6亞烷基苯基Cu烷基、〇-乙烯氨基 曱酸和0-乙烯碳酸。非限定的陽離子反應官能基的例 子包括乙烯醚或者環氧官能基和其混合物。在一實施 例中自由基反應官能基包括(甲基)丙烯酸、丙烯酸氧 基、(曱基)丙烯醯胺及其混合物。 合適的單價烧基和芳香族烴基包括無取代單價Ci 至C16烧基、C6至Ci4芳香族煙基,例如取代和無取 代曱基、乙基、丙基、丁基、2-氫氧基丙基、丙醯氧 丙基、聚亞甲基氧丙基,其組合等等。 201029831 在一實施例中b為0 ’ 一 R1為單價反應官能基, 且至少3個ri係從具有1至16個碳原子的單價烷基 選出’且另一實施例中係從具有1至6個碳原子的單 價烷基選出。本實施例之非限定的含聚矽氧組分例子 包括甲基,2_氫氧基·3·[3_[1,3,3,3-四甲基小[(三甲基 曱矽炫基)氧]曱矽醚基]丙醯氧]丙脂(“SiGMA”), 2- 氫氧基-3-甲基丙烯酸氧基丙醯氧丙基-三(三甲基矽 氧基)矽烷, ❿ 3-曱基丙烯酸氧基丙基三(三甲基矽氧基)矽烷 (“TRIS”), 3- 甲基丙烯酸氧基丙基二(三曱基矽氧基)甲基矽烷和 3-曱基丙烯酸氧基丙基五曱基二矽氧烷。 在另一實施例中’b為2至20、3至15,或者在 一些實施例中為3至10;至少一末端R1包括一單價反 應官能基’而剩下的R1係從具有1至16個碳原子的 單價烷基選出,且在另一實施例中係從具有1至6個 ❹ 碳原子的單價烷基選出。在又一實施例中,b為3至 15 ’ 一末端R1包括一單價反應官能基,另一末端Ri 則包括具有1至6個碳原子的單價烧基且剩下的R1包 括具有1至3個碳原子的單價烧基。本實施例之非限 • 定的含聚矽氧組分例子包括(單-(2-氳氧基-3-甲基丙烯 酸氧基丙基)-丙基醚端的聚二曱基矽氧烧(分子量為 4〇〇至1000)) (“〇H-mPDMS,,),單甲基丙烯酸氧基丙 基端單正丁基端的聚二曱基矽氧烷(分子量為8〇〇至 1000),(“mPDMS”)。 17 201029831 在另厂實施例中,b為5至4〇〇或從1〇至3〇〇, 兩末端R1包括單價反應官能基,而剩下的Rl係個別 從具有1至18個碳原子的單價烷基選出,其中該單價 燒基可包括在碳原子間的醚類鏈結、更可包括鹵素。、 在一實施例中,若想獲得聚矽氧水膠透鏡,本 明的透鏡將由包括重量百分比至少約2〇%的活性混合 物所製成’較佺情況為含聚矽氧組分佔所製成之/聚^ 物的反應單體組分總重的約2〇%至7〇%間。 在另一實施例中的,1至4個R1包括分子式的乙 稀碳酸鹽或者氨基甲酸鹽:b R wherein R1 is an individual selected from the aromatic hydrocarbon group of 201029831, an amino group, a heterocyclic oxy group, a carboxyl group, an alkylcarboxy group, an alkoxy group, an amine group, a carbamic acid, a carbonic acid, a dentate or a combination thereof. And a monovalent oxyalkylene chain comprising from 1 to 100 Si-oxime repeating units may further be derived from an alkyl group, a hydroxyl group, an amino group, a heterocyclic oxy group, a fluorenyl group, an alkyl group, an alkoxy group, a functional group selected from an amine group, a hydroxy group, a halogen or a combination thereof; wherein b = 0 to 500, it is understood that when b is not equal to 0, then b is a distribution having a mode equivalent to a specified value; wherein at least one R1 includes Monovalent reactive functional groups, and in some embodiments between one and three R1 include monovalent reactive functional groups. As used herein, "monovalent reactive functional group" as used herein is a functional group capable of undergoing radical and/or cationic polymerization. Examples of non-limiting radical reactive functional groups include (meth)acrylic acid, styryl, vinyl, vinyl ether, Ck alkyl (meth)acrylic acid, (mercapto) acrylamide, Ck alkyl (fluorenyl) Acrylamide, N-vinylamine, N-vinyl lactam, (: 2-12 alkylene, C2-12 alkylene phenyl, C2-12 alkylene naphthyl, C2-6 alkylene phenyl Cu alkyl, Anthracene-ethylene aminononanoic acid and 0-ethylene carbonate. Examples of non-limiting cationic reactive functional groups include vinyl ether or epoxy functional groups and mixtures thereof. In one embodiment, the free radical reactive functional groups include (meth)acrylic acid, Acrylic acid oxy, (fluorenyl) acrylamide and mixtures thereof. Suitable monovalent alkyl and aromatic hydrocarbon groups include unsubstituted monovalent Ci to C16 alkyl, C6 to Ci4 aromatic fluorenyl, such as substituted and unsubstituted thiol groups, Ethyl, propyl, butyl, 2-hydroxyoxypropyl, propionyloxypropyl, polymethyleneoxypropyl, combinations thereof, etc. 201029831 In one embodiment b is 0 'one R1 is a unit price a reactive functional group, and at least 3 ri are from a monovalent alkyl group having from 1 to 16 carbon atoms Elected from 'and another embodiment is selected from a monovalent alkyl group having 1 to 6 carbon atoms. Examples of non-limiting polyoxonium-containing components of this embodiment include methyl, 2-hydroxyl·3·[ 3_[1,3,3,3-Tetramethyl small [(trimethylsulfonyl)oxy] oxime ether] propionium oxy] propyl ester ("SiGMA"), 2-hydroxyl-3 - oxypropoxypropyl methacrylate-tris(trimethyldecyloxy)decane, ❿ 3-mercapto oxypropyltris(trimethyldecyloxy)decane ("TRIS"), 3 - oxypropyl bis(trimethyl decyloxy)methyl decyl methacrylate and methoxypropyl pentadecyldioxane 3-mercapto acrylate. In another embodiment 'b is 2 to 20 3 to 15, or in some embodiments 3 to 10; at least one terminal R1 comprises a monovalent reactive functional group' and the remaining R1 is selected from a monovalent alkyl group having from 1 to 16 carbon atoms, and in another In one embodiment, it is selected from a monovalent alkyl group having from 1 to 6 carbon atoms. In yet another embodiment, b is from 3 to 15'. One end R1 includes a monovalent reactive functional group, and the other end Ri includes a monovalent alkyl group of 1 to 6 carbon atoms and The remaining R1 includes a monovalent alkyl group having 1 to 3 carbon atoms. Examples of the non-limiting polyoxonium-containing component of the present embodiment include (mono-(2-decyloxy-3-methacrylic acid) Polypropylidene oxime at the propyl-propyl ether end (molecular weight 4〇〇 to 1000)) ("〇H-mPDMS,"), oxypropyl-terminated mono-n-butyl end of monomethacrylate Polydimethyl fluorenyl oxane (molecular weight 8 〇〇 to 1000), ("mPDMS"). 17 201029831 In another embodiment, b is 5 to 4 〇〇 or from 1 〇 to 3 〇〇, both ends R1 includes a monovalent reactive functional group, and the remaining R1 is selected individually from a monovalent alkyl group having from 1 to 18 carbon atoms, wherein the monovalent alkyl group may include an ether linkage between carbon atoms, and may further include a halogen. In one embodiment, if a polyxide water gel lens is to be obtained, the lens of the present invention will be made of an active mixture comprising at least about 2% by weight, which is a component containing a polyoxyxide component. Between about 2% and 7〇% of the total weight of the reactive monomer components of the polymer/polymer. In another embodiment, 1 to 4 R1 comprise a vinyl carbonate or carbamate of the formula:
分子式II R 〇Molecular Formula II R 〇
H2C=c—(CH2)q-〇-C-Y 其中:Y表示〇·、S-或者NH-; R表示氫或者甲基;(1是1、2、3或者4;而q是〇 者1。 含聚石夕氧的乙烯碳酸鹽或者乙烯氨基曱酸單體具 體上包括:1,3-二[4-(乙烯氧羰氧基)丁_1_基]四甲基_ 二矽氧烷;3-(乙烯氧羰硫代)丙基_[三(三曱基矽氧基) 矽烷];3-[三(三甲基矽氧基)甲矽焱基]丙基丙烯基氨基 甲酸;3-[三(三曱基矽氧基)甲矽烷基]丙基乙烯氨基甲 酸;三甲基甲矽烷基乙基乙烯碳酸鹽;三甲基甲矽烷 基甲基乙烯碳酸鹽與 201029831 ο ch3 H2c=c—OCO(CH3)4-Si一0- CH3 ch3 -Si——O I ch3 ch3 o •Si—0 ch3 ch2)4oco—c=ch2 若想獲得係數約低於200的生物醫療裝置,僅有 一 R1應包括一單價反應官能基,且不超過兩個的剩下 R1官能基將包括單價矽氧烷官能基。 φ 另一類的含聚矽氧組分包括下列分子式的聚胺曱 酸酯大分子單體:H2C=c—(CH2)q-〇-CY wherein: Y represents 〇·, S- or NH-; R represents hydrogen or methyl; (1 is 1, 2, 3 or 4; and q is 〇1). The polyoxonium-containing ethylene carbonate or ethylene amino phthalic acid monomer specifically includes: 1,3-bis[4-(vinyloxycarbonyloxy)butyl-1-yl]tetramethyl-dioxane; 3-(vinyloxycarbonylthio)propyl-[tris(tridecyloxy)decane]; 3-[tris(trimethyldecyloxy)methylindolyl]propylpropenylcarbamic acid; -[Tris(tridecyloxy)carbinyl]propylvinylcarbamate; trimethylformamidinylethylethylene carbonate; trimethylformamylmethylethylene carbonate and 201029831 ο ch3 H2c= c—OCO(CH3)4-Si-0-CH3 ch3 -Si——OI ch3 ch3 o •Si—0 ch3 ch2)4oco—c=ch2 If you want to obtain a biomedical device with a coefficient of less than 200, only one R1 A monovalent reactive functional group should be included, and no more than two remaining R1 functional groups will include a monovalent oxyalkylene functional group. φ Another class of polyoxonium-containing components includes polyamine phthalate macromonomers of the following formula:
分子式IV-VI (*D*A*D*G)a *D*D*E]; E(*D*G*D*A)a *D*G*D*E1 或者 癰 E(*D*A*D*G)fl *D*A*D*E1 其中: D表示具有6至30個碳原子的烷基二自由基、烷 基環烷基二自由基、環烷基二自由基、芳香族烴基二 自由基或者烷基芳香族烴基二自由基, G表示具有1至40個碳原子且其主鏈内可包含有 醚類、硫代或者胺類鏈結的烷基二自由基、環烷基二 19 201029831 自由基、烧基環炫基'一自由基、方香族煙基二自由基 或者烷基芳香族烴基二自由基’ *表示氨基鉀酸酯或者脲基鏈結; α至少為1 ; Α表示分子式的二價聚合自由基:Formula IV-VI (*D*A*D*G)a *D*D*E]; E(*D*G*D*A)a *D*G*D*E1 or 痈E(*D* A*D*G)fl *D*A*D*E1 wherein: D represents an alkyl diradical having 6 to 30 carbon atoms, an alkylcycloalkyl diradical, a cycloalkyl diradical, an aromatic a hydrocarbon-based diradical or an alkylaromatic hydrocarbyl diradical, G represents an alkyl diradical having 1 to 40 carbon atoms and having an ether, thio or amine chain in its main chain, and a ring Alkyl sulphide 19 201029831 free radical, alkyl ring cyclyl 'free radical, scented fluorenyl diradical or alkyl aromatic hydrocarbyl diradical' * represents a urethane or urea chain; Is 1; Α represents the molecular formula of the divalent polymerization radical:
分子式VIIMolecular formula VII
-Riti I SiO-Riti I SiO
R 11 (CH2)yj*SiOj-Si—(CH2)y一 11R 11 (CH2)yj*SiOj-Si—(CH2)y-11
RR
R_ PR_ P
R11個別表示具有l至10個碳原子且其碳原子間包含 有越類鏈結的炫基或氟取代烧基;y至少為1 ;並且p 提供400至10,000的部分重量(moiety weight) ; E和 E1各自表示可聚合不飽和有機自由基,其由下列分子 分子式表示:R11 individually represents a leukoyl group or a fluorine-substituted alkyl group having 1 to 10 carbon atoms and having a more branched chain between carbon atoms; y is at least 1; and p provides a moiety weight of 400 to 10,000; And E1 each represent a polymerizable unsaturated organic radical, which is represented by the following molecular formula:
分子式VIII R12 R13CH=C-(CH2)w-(X)x-(Z)z-(Ar)y~R14—Molecular formula VIII R12 R13CH=C-(CH2)w-(X)x-(Z)z-(Ar)y~R14-
其中:R12為氫或者甲基;R13為氫、具有丨至6個碳 原子的烧基自由基或者一CO—Y—R15自由基,其中γ 為—〇—,Y—S—或者一NH—; R14為具有丄至12個碳 原子的二價自由基;X表示—c〇—或者—〇co— ; Z 20 201029831 表示一〇—或者〜NH〜,射 子的芳香自由基;W為0至6;x為·^30個碳原 或者1,.而Z為〇或者i。 ”、、或者hy為〇 製程 下列方法步驟為可根據本發明一 解’呈現之方法步驟的順 步驟均需用以實施本發 卜並非所有 包括其他步驟。 之各種實施例可 清參閱圖4’此流程圖顯 步驟。在•將資料處理器放置 在一些實施例中,資料虚播路〜 棋具零件内。 内。在402 ’反應活性單體混合物可沉積在模具零件 在403 ’將資料處理器放置於模具零件内 :實施例中’㈣料處理器⑴透過機械 放置於模具零件内。例 的方式 手臂或其他自動化以機械放置方式可包括機器 株夕p ^ 系統,例如業界内放置表面黏著組 資料組:理範圍亦包括採人工方式放置 料處理器放置於鑄模含能量來源之資 性混合物產生聚合作具零件包含之活 眼科透鏡内的可變光^機械放置方法’將包括合成 21 201029831 在一些實施例中,處理器設備、MEMS、NEMS 或其他組件亦可放置於資料處理器中與含能量來源之 電接點内。 在404,第一個模具組件可放置於接近第二個模 具組件之處以形成成鏡孔穴,孔穴内含至少一些活性 單體混合物與能量來源。在405,孔穴内之活性單競 混合物可被聚合。例如’聚合作用可透過曝露於光化 輻射或熱能或兩者均暴露的方式達成。在406,透鏡 自模具零件卸下。Wherein: R12 is hydrogen or methyl; R13 is hydrogen, a pyridyl radical having from 丨 to 6 carbon atoms or a CO—Y—R15 radical, wherein γ is —〇—, Y—S— or an NH— R14 is a divalent radical having 丄 to 12 carbon atoms; X represents -c〇- or -〇co-; Z 20 201029831 represents a 〇- or ~NH~, an aromatic radical of the emitter; W is 0 To 6; x is · ^ 30 carbon atoms or 1, and Z is 〇 or i. The following method steps are the steps of the method steps that can be presented in accordance with the present invention. All of the steps are required to implement the present invention. Not all of the other steps are included. Various embodiments can be referred to FIG. 4' This flowchart shows the steps. In the case of placing the data processor in some embodiments, the data is imaginary road ~ inside the chess piece. Inside. The 'reactive monomer mixture can be deposited in the mold part at 403' will be the data processor Placed in the mold part: in the embodiment, the '(4) material processor (1) is placed in the mold part through the machine. The way of the arm or other automated mechanical placement may include the machine system, such as placing the surface adhesion group in the industry. Data group: The scope of the rationale also includes the manual placement of the material processor placed in the mold containing the energy source of the mixture of resources to produce a variable opto-mechanical placement method in the ophthalmic lens contained in the colloidal part' will include synthesis 21 201029831 In some embodiments, the processor device, MEMS, NEMS, or other components may also be placed in the data processor with energy Within the electrical contact of the source. At 404, the first mold assembly can be placed adjacent to the second mold assembly to form a mirrored cavity containing at least some active monomer mixture and energy source. At 405, within the cavity The active single-race mixture can be polymerized. For example, 'polymerization can be achieved by exposure to actinic radiation or thermal energy or both. At 406, the lens is removed from the mold part.
雖然發明可用於提供以任何已知透鏡材料或適> 製造此類透鏡之材料製成的硬式或軟式隱形眼鏡,^ 本發明之較佳透鏡則是水含量在約〇至9〇%之間的」 式隱形眼鏡。更佳之透鏡應以包含羥基、羰基或兩 之單體製成,或以含聚;δ夕氧之聚合物製成,例如矽: 烷、水膠、矽水膠及其組合。對於本發明透鏡之成: 有用之材料可採用如聚合反應起始劑等的添加劑使 分子單體、單體及其組合之摻合物發生反應來製成 合適之材料包括但不限於以聚矽氧大分子單j (Silicone Macromer)及親水性單元體物加刺 Monomer)製成之矽水膠。 請參閱圖4,在403,活性混合物放置於第一 具零件與第二健具料之間,且㈣料處理器^ =在404,第一個模具零件放置於接近第二個模』 以形成透鏡孔穴,並使活性單體混合物以: 可變透鏡位於透鏡孔穴内。 22 201029831 在405,活性混合物發生聚合作用,例如透過曝 露於光化輻射或熱能或兩者均暴露的方式達成。在 406,加入資料處理器之眼科設備自模具零件卸下。 請參閱圖5 ’在501,資料處理器放置於眼科透鏡 内,如以上所述。在502,資料處理器與能量來源形 成電子通訊。例如,電子通訊可透過結合入資料處理 器之電路或透過直接在透鏡材料上嘴墨或其他形成之 路徑達成。While the invention can be used to provide a rigid or soft contact lens made of any known lens material or material suitable for making such lenses, the preferred lens of the present invention has a water content of between about 〇 and 9〇%. Contact lenses. More preferably, the lens should be made of a monomer comprising a hydroxyl group, a carbonyl group or two, or a polymer containing a polyoxane, such as an anthracene, a water gel, a hydrophobic gel, and combinations thereof. For the formation of the lens of the present invention: Useful materials may be prepared by reacting a blend of molecular monomers, monomers and combinations thereof with an additive such as a polymerization initiator to form suitable materials including, but not limited to, polyfluorene. A hydrophobic gel made of an oxygen macromolecular single j (Silicone Macromer) and a hydrophilic unit body punctured Monomer. Referring to FIG. 4, at 403, the active mixture is placed between the first part and the second material, and (4) the material processor ^ = at 404, the first mold part is placed close to the second mold to form The lens apertures and the active monomer mixture are: The variable lens is located within the lens aperture. 22 201029831 At 405, the active mixture is polymerized, for example by exposure to actinic radiation or thermal energy or both. At 406, the ophthalmic device incorporating the data processor is removed from the mold part. Referring to Figure 5' at 501, the data processor is placed in the ophthalmic lens as described above. At 502, the data processor forms an electronic communication with the energy source. For example, electronic communication can be accomplished by incorporating circuitry into the data processor or by direct ink or other formed paths on the lens material.
罄 在503將電能導通過結合於眼科透鏡内之資料處 理器。例如,能量可透過可傳達電荷之電路導入。在 504,可變光學改變透鏡至少一光學特質。 裝置 '、請參閱圖3 ’自動化裝置310具有-項或數項傳 丨面311。如圖不,數個模組零件均關聯包含在托 反313内之模具零件容器314,且呈現給傳送介面 11傳送;| * 311將把處理器或包含處理器之嵌件放 入用於成形眼科透鏡之模具零件314内。實施例可包 ,別:置資料處理器之單-介面,或同時將數個處 态放於數個模具組件内之數個介面(未顯示卜且 在-些“_中’則是放置於每個模具零件。 夕, 甘二ϊΐ施例之另一態樣包括支持包含資料處理器 、二的裝置’同時眼科透鏡主體亦在這些組件 :圍成:在一些實施例中,能量 模具内的吸持點上r去骷_、 未)。吸持點可使用與形成透 煢主體之_型聚合材料固定。 23 201029831 請參聞圖6,控制器600可用於本發明一些實施 例。控制器600包括處理器610,該處理器可包栝/ 個或多個與通訊設備620耦合之處理器組件。在〆# 實施例中,控制器600可用於將能量傳輸至放置於眼 科透鏡内的能量來源。 控制ϋ可包括一個或數個處理器,其與設定為透 過通訊通道來傳輸能量之通訊設備耦合。通訊設備玎 用於以電子控制一個或多個:將可變光學嵌件放入眼 科透鏡以及傳輸命令以操作可變光學設備之動作。 0 例如’通訊設備620亦可用於與一個或數個控制 器裝置或製造設備組件通訊。 處理器610亦與儲存設備630進行通訊。儲存設 備630可包括任何合適之資訊儲存設備,包括磁性儲 存設備、(例如磁帶機及硬碟)、光學儲存裝置及/或半 導體記憶裝置如隨機存取記憶體(RAM)設備與唯讀記 憶體(ROM)設備等組合。 ° 儲存設備630可儲存控制處理器61〇之程式64〇。 處理器610執行程式640的指令,因此根據本發明運❹ 作。例如,處理器610可接收可變光學插件放置、處 理設備放置等諸如此類的資訊說明。儲存設備63〇亦 可在-個或多個資料庫中儲存眼科相關資料。資料庫 可包括自βΤ之媒體祕料、量測資料及控制進 · 體嵌件能量之特定控制順序。 、 結論 24 201029831 如以上所述並更以下列申請之專利範圍定義, 發明提供製造含資料處理ϋ之能量化透鏡的方法與實 施此類方法之裝置,以及成形有上述資料處理器之眼 科透鏡。 置罄 Conduct electrical energy at 503 through a data processor incorporated into the ophthalmic lens. For example, energy can be introduced through a circuit that can carry a charge. At 504, the variable optics alters at least one optical characteristic of the lens. The device ', please refer to FIG. 3', the automation device 310 has a - or a plurality of transmission surfaces 311. As shown, a plurality of module parts are associated with the mold part container 314 contained in the counter 313 and presented to the transfer interface 11 for transfer; | * 311 will place the processor or the insert containing the processor for forming Inside the mold part 314 of the ophthalmic lens. Embodiments may include, do not: set the single-interface of the data processor, or simultaneously place several states in several interfaces in several mold components (not shown and in some "_" is placed Each of the mold parts. Another aspect of the singular embodiment includes supporting a device comprising a data processor, two. At the same time, the ophthalmic lens body is also in these components: enclosing: in some embodiments, within the energy mold The suction point is r to 骷, not. The suction point can be fixed using the _ type polymeric material forming the permeable body. 23 201029831 Please refer to Figure 6, the controller 600 can be used in some embodiments of the invention. 600 includes a processor 610 that can include one or more processor components coupled to communication device 620. In an embodiment, controller 600 can be used to transfer energy to energy placed in an ophthalmic lens. The control unit may include one or more processors coupled to a communication device configured to transmit energy through the communication channel. The communication device is configured to electronically control one or more: placing the variable optical insert into the ophthalmology department Lens and The command is input to operate the variable optical device. 0 For example, the communication device 620 can also be used to communicate with one or several controller devices or manufacturing device components. The processor 610 also communicates with the storage device 630. The storage device 630 can include Any suitable information storage device, including magnetic storage devices, such as tape drives and hard drives, optical storage devices, and/or semiconductor memory devices such as random access memory (RAM) devices and read only memory (ROM) devices The storage device 630 can store the program 64 of the control processor 61. The processor 610 executes the instructions of the program 640 and thus operates in accordance with the present invention. For example, the processor 610 can receive the variable optical card placement and processing device. Information such as placement, etc. The storage device 63 can also store ophthalmology-related data in one or more databases. The database can include media secrets from beta, measurement data, and control of body insert energy. Specific control sequence., Conclusion 24 201029831 As described above and further defined by the patent scope of the following application, the invention provides manufacturing information The energy management ϋ lens apparatus and a method of implementing such methods, as well as ophthalmic lenses formed with the above information processor. Counter
態樣 圖式簡單說明】 。圖1係根據本發明之—些實施例之模具總成農 圖2係含包括資料處理器之媒體巍件之眼科透 鏡 透鏡模具括㈣處理之舰嵌件放入眼科 =艮據本發明一些實施例之方法步驟。 圖其㈣狀枝步驟。 器。 ;只本發明之一些實施例之處理The pattern is a simple description]. 1 is a mold assembly according to some embodiments of the present invention. FIG. 2 is an ophthalmic lens lens mold including a media element including a data processor. (4) The ship insert is processed into an ophthalmology group according to some embodiments of the present invention. Example method steps. Figure (4). Device. Only processing of some embodiments of the invention
之透視 =圖7係包括處理器及組件之-些眼科透鏡實施例 25 201029831 【主要元件符號說明】 100. 眼科透鏡 101. 模具零件 102. 模具零件 103. 表面 104. 表面 105. 孔穴 108. 液態凹凸透鏡部分 109. 能量來源 111.資料處理器 200. 眼科透鏡 201. 嵌件 202. 光感器 203. 組件 204. 處理器 205. 啟動器 206. 光 207. 水膠透鏡材料 208. 能量來源 310. 自動化裝置 311. 傳送介面 313. 托板 314. 模具零件容器 600.控制器 610.處理器 620.通訊設備 630.儲存設備 640.程式 650.資料庫 660.資料庫 26Perspectives Figure 7 is a series of ophthalmic lenses including processors and components. Example 25 201029831 [Major component symbol description] 100. Ophthalmic lens 101. Mold part 102. Mold part 103. Surface 104. Surface 105. Hole 108. Liquid Concave lens portion 109. Energy source 111. Data processor 200. Ophthalmic lens 201. Insert 202. Light sensor 203. Component 204. Processor 205. Starter 206. Light 207. Hydrogel lens material 208. Energy source 310 Automation device 311. Transfer interface 313. Pallet 314. Mold part container 600. Controller 610. Processor 620. Communication device 630. Storage device 640. Program 650. Database 660.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11021308P | 2008-10-31 | 2008-10-31 | |
US12/578,720 US9375885B2 (en) | 2008-10-31 | 2009-10-14 | Processor controlled ophthalmic device |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201029831A true TW201029831A (en) | 2010-08-16 |
TWI516362B TWI516362B (en) | 2016-01-11 |
Family
ID=41698274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW098136787A TWI516362B (en) | 2008-10-31 | 2009-10-30 | Processor controlled ophthalmic device |
Country Status (14)
Country | Link |
---|---|
US (1) | US9375885B2 (en) |
EP (1) | EP2349699B1 (en) |
JP (1) | JP6067224B2 (en) |
KR (1) | KR101678840B1 (en) |
CN (1) | CN102271900B (en) |
AR (1) | AR074017A1 (en) |
AU (1) | AU2009309034B2 (en) |
BR (1) | BRPI0919957B1 (en) |
CA (1) | CA2741922C (en) |
IL (1) | IL212528A (en) |
RU (1) | RU2506163C2 (en) |
SG (1) | SG195614A1 (en) |
TW (1) | TWI516362B (en) |
WO (1) | WO2010051203A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI612358B (en) * | 2013-03-15 | 2018-01-21 | 壯生和壯生視覺關懷公司 | Ophthalmic device and method for removably attaching a media insert to a hydrogel lens |
Families Citing this family (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9675443B2 (en) | 2009-09-10 | 2017-06-13 | Johnson & Johnson Vision Care, Inc. | Energized ophthalmic lens including stacked integrated components |
US20100078837A1 (en) * | 2008-09-29 | 2010-04-01 | Pugh Randall B | Apparatus and method for formation of an energized ophthalmic device |
US8348424B2 (en) * | 2008-09-30 | 2013-01-08 | Johnson & Johnson Vision Care, Inc. | Variable focus ophthalmic device |
US9375886B2 (en) * | 2008-10-31 | 2016-06-28 | Johnson & Johnson Vision Care Inc. | Ophthalmic device with embedded microcontroller |
US9375885B2 (en) | 2008-10-31 | 2016-06-28 | Johnson & Johnson Vision Care, Inc. | Processor controlled ophthalmic device |
US9446262B2 (en) * | 2011-02-04 | 2016-09-20 | Johnson & Johnson Vision Care, Inc. | Apparatus and method for formation of an energized ophthalmic device for light therapy |
US8950862B2 (en) | 2011-02-28 | 2015-02-10 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for an ophthalmic lens with functional insert layers |
US10451897B2 (en) | 2011-03-18 | 2019-10-22 | Johnson & Johnson Vision Care, Inc. | Components with multiple energization elements for biomedical devices |
US9698129B2 (en) | 2011-03-18 | 2017-07-04 | Johnson & Johnson Vision Care, Inc. | Stacked integrated component devices with energization |
US9233513B2 (en) | 2011-03-18 | 2016-01-12 | Johnson & Johnson Vision Care, Inc. | Apparatus for manufacturing stacked integrated component media inserts for ophthalmic devices |
US9110310B2 (en) | 2011-03-18 | 2015-08-18 | Johnson & Johnson Vision Care, Inc. | Multiple energization elements in stacked integrated component devices |
US9195075B2 (en) | 2011-03-21 | 2015-11-24 | Johnson & Johnson Vision Care, Inc. | Full rings for a functionalized layer insert of an ophthalmic lens |
US9804418B2 (en) * | 2011-03-21 | 2017-10-31 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for functional insert with power layer |
RU2594435C2 (en) * | 2011-08-31 | 2016-08-20 | Джонсон Энд Джонсон Вижн Кэа, Инк. | Intraocular lens system with processor control |
CA2893694C (en) | 2011-12-06 | 2019-05-14 | E-Vision Smart Optics, Inc. | Systems, devices, and/or methods for providing images |
US8857983B2 (en) | 2012-01-26 | 2014-10-14 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens assembly having an integrated antenna structure |
US9134546B2 (en) | 2012-02-22 | 2015-09-15 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with segmented ring layers in a functionalized insert |
US9351827B2 (en) * | 2012-04-03 | 2016-05-31 | Johnson & Johnson Vision Care, Inc. | Lens driver for variable-optic electronic ophthalmic lens |
US8798332B2 (en) | 2012-05-15 | 2014-08-05 | Google Inc. | Contact lenses |
US10423011B2 (en) * | 2012-06-14 | 2019-09-24 | Mitsui Chemicals, Inc. | Lens, lens blank, and eyewear |
US9442305B2 (en) | 2012-06-14 | 2016-09-13 | Mitsui Chemicals, Inc. | Electronic eyeglasses and methods of manufacturing |
US9523865B2 (en) | 2012-07-26 | 2016-12-20 | Verily Life Sciences Llc | Contact lenses with hybrid power sources |
US9158133B1 (en) | 2012-07-26 | 2015-10-13 | Google Inc. | Contact lens employing optical signals for power and/or communication |
US9298020B1 (en) | 2012-07-26 | 2016-03-29 | Verily Life Sciences Llc | Input system |
US8857981B2 (en) | 2012-07-26 | 2014-10-14 | Google Inc. | Facilitation of contact lenses with capacitive sensors |
US8919953B1 (en) | 2012-08-02 | 2014-12-30 | Google Inc. | Actuatable contact lenses |
US9696564B1 (en) | 2012-08-21 | 2017-07-04 | Verily Life Sciences Llc | Contact lens with metal portion and polymer layer having indentations |
US8971978B2 (en) | 2012-08-21 | 2015-03-03 | Google Inc. | Contact lens with integrated pulse oximeter |
US9111473B1 (en) | 2012-08-24 | 2015-08-18 | Google Inc. | Input system |
US8820934B1 (en) | 2012-09-05 | 2014-09-02 | Google Inc. | Passive surface acoustic wave communication |
US20140192315A1 (en) | 2012-09-07 | 2014-07-10 | Google Inc. | In-situ tear sample collection and testing using a contact lens |
US9398868B1 (en) | 2012-09-11 | 2016-07-26 | Verily Life Sciences Llc | Cancellation of a baseline current signal via current subtraction within a linear relaxation oscillator-based current-to-frequency converter circuit |
US10010270B2 (en) | 2012-09-17 | 2018-07-03 | Verily Life Sciences Llc | Sensing system |
US9326710B1 (en) | 2012-09-20 | 2016-05-03 | Verily Life Sciences Llc | Contact lenses having sensors with adjustable sensitivity |
US8870370B1 (en) | 2012-09-24 | 2014-10-28 | Google Inc. | Contact lens that facilitates antenna communication via sensor impedance modulation |
US8960898B1 (en) | 2012-09-24 | 2015-02-24 | Google Inc. | Contact lens that restricts incoming light to the eye |
US20140088372A1 (en) | 2012-09-25 | 2014-03-27 | Google Inc. | Information processing method |
US8979271B2 (en) | 2012-09-25 | 2015-03-17 | Google Inc. | Facilitation of temperature compensation for contact lens sensors and temperature sensing |
US8989834B2 (en) | 2012-09-25 | 2015-03-24 | Google Inc. | Wearable device |
US9884180B1 (en) | 2012-09-26 | 2018-02-06 | Verily Life Sciences Llc | Power transducer for a retinal implant using a contact lens |
US8960899B2 (en) | 2012-09-26 | 2015-02-24 | Google Inc. | Assembling thin silicon chips on a contact lens |
US8985763B1 (en) | 2012-09-26 | 2015-03-24 | Google Inc. | Contact lens having an uneven embedded substrate and method of manufacture |
US8821811B2 (en) | 2012-09-26 | 2014-09-02 | Google Inc. | In-vitro contact lens testing |
US9063351B1 (en) | 2012-09-28 | 2015-06-23 | Google Inc. | Input detection system |
US8965478B2 (en) | 2012-10-12 | 2015-02-24 | Google Inc. | Microelectrodes in an ophthalmic electrochemical sensor |
US9176332B1 (en) | 2012-10-24 | 2015-11-03 | Google Inc. | Contact lens and method of manufacture to improve sensor sensitivity |
US9757056B1 (en) | 2012-10-26 | 2017-09-12 | Verily Life Sciences Llc | Over-molding of sensor apparatus in eye-mountable device |
CN105122119B (en) | 2012-12-06 | 2017-06-09 | E-视觉有限公司 | System, device, and/or the method for image are provided |
SG2013091087A (en) * | 2013-01-09 | 2014-08-28 | Johnson & Johnson Vision Care | Multi-piece insert device with glue seal for ophthalmic devices |
SG2013091095A (en) | 2013-01-09 | 2014-08-28 | Johnson & Johnson Vision Care | Method of forming a multi-piece insert device with seal for ophthalmic devices |
EP3225385A1 (en) * | 2013-01-09 | 2017-10-04 | Johnson & Johnson Vision Care Inc. | Method of forming a multi-piece insert device with seal for ophthalmic devices and a multi-piece insert device with glue seal for ophthalmic devices |
US8874182B2 (en) | 2013-01-15 | 2014-10-28 | Google Inc. | Encapsulated electronics |
US9289954B2 (en) | 2013-01-17 | 2016-03-22 | Verily Life Sciences Llc | Method of ring-shaped structure placement in an eye-mountable device |
US20140209481A1 (en) | 2013-01-25 | 2014-07-31 | Google Inc. | Standby Biasing Of Electrochemical Sensor To Reduce Sensor Stabilization Time During Measurement |
US9636016B1 (en) | 2013-01-25 | 2017-05-02 | Verily Life Sciences Llc | Eye-mountable devices and methods for accurately placing a flexible ring containing electronics in eye-mountable devices |
US10025114B2 (en) * | 2013-03-13 | 2018-07-17 | Johnson & Johnson Vision Care, Inc. | Hydrogel lens having raised portions for improved oxygen transmission and tear flow |
IL231446A0 (en) * | 2013-03-15 | 2014-08-31 | Johnson & Johnson Vision Care | Methods and ophthalmic device for providing visual representations to a user |
US9307654B2 (en) * | 2013-03-15 | 2016-04-05 | Johnson & Johnson Vision Care, Inc. | Method of forming a patterned multi-piece insert for an ophthalmic lens |
US9329410B2 (en) * | 2013-03-15 | 2016-05-03 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lenses with colorant patterned inserts |
US9069186B2 (en) | 2013-03-15 | 2015-06-30 | Johnson & Johnson Vision Care, Inc. | Thermoformed ophthalmic insert devices |
US9316848B2 (en) * | 2013-03-15 | 2016-04-19 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices with stabilization features |
US9481124B2 (en) * | 2013-03-15 | 2016-11-01 | Johnson & Johnson Vision Care, Inc. | Method and apparatus for forming thermoformed ophthalmic insert devices |
US9873233B2 (en) * | 2013-03-15 | 2018-01-23 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens viewing sets for three-dimensional perception of stereoscopic media |
US9310626B2 (en) * | 2013-03-15 | 2016-04-12 | Johnson & Johnson Vision Care, Inc. | Ophthalmic devices with organic semiconductor transistors |
US9161712B2 (en) | 2013-03-26 | 2015-10-20 | Google Inc. | Systems and methods for encapsulating electronics in a mountable device |
US9113829B2 (en) | 2013-03-27 | 2015-08-25 | Google Inc. | Systems and methods for encapsulating electronics in a mountable device |
US9429769B2 (en) * | 2013-05-09 | 2016-08-30 | Johnson & Johnson Vision Care, Inc. | Ophthalmic device with thin film nanocrystal integrated circuits |
US10213140B2 (en) * | 2013-05-17 | 2019-02-26 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with a microfluidic system |
US9897824B2 (en) * | 2013-05-17 | 2018-02-20 | Johnson & Johnson Vision Care, Inc. | Method and device for monitoring ophthalmic lens manufacturing conditions |
US8967488B2 (en) * | 2013-05-17 | 2015-03-03 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with communication system |
US9915829B2 (en) * | 2013-05-21 | 2018-03-13 | Johnson & Johnson Vision Care, Inc. | Method of manufacturing an ophthalmic lens with a passive event-based coloration system |
US9977256B2 (en) * | 2013-05-30 | 2018-05-22 | Johnson & Johnson Vision Care, Inc. | Methods for manufacturing and programming an energizable ophthalmic lens with a programmable media insert |
US20140371560A1 (en) | 2013-06-14 | 2014-12-18 | Google Inc. | Body-Mountable Devices and Methods for Embedding a Structure in a Body-Mountable Device |
US9084561B2 (en) | 2013-06-17 | 2015-07-21 | Google Inc. | Symmetrically arranged sensor electrodes in an ophthalmic electrochemical sensor |
US9948895B1 (en) | 2013-06-18 | 2018-04-17 | Verily Life Sciences Llc | Fully integrated pinhole camera for eye-mountable imaging system |
US9685689B1 (en) | 2013-06-27 | 2017-06-20 | Verily Life Sciences Llc | Fabrication methods for bio-compatible devices |
US9492118B1 (en) | 2013-06-28 | 2016-11-15 | Life Sciences Llc | Pre-treatment process for electrochemical amperometric sensor |
US9814387B2 (en) | 2013-06-28 | 2017-11-14 | Verily Life Sciences, LLC | Device identification |
US9028772B2 (en) | 2013-06-28 | 2015-05-12 | Google Inc. | Methods for forming a channel through a polymer layer using one or more photoresist layers |
US9307901B1 (en) | 2013-06-28 | 2016-04-12 | Verily Life Sciences Llc | Methods for leaving a channel in a polymer layer using a cross-linked polymer plug |
US9185486B2 (en) * | 2013-08-27 | 2015-11-10 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with micro-acoustic elements |
US9801560B2 (en) | 2013-08-27 | 2017-10-31 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with a neural frequency detection system |
US9170646B2 (en) * | 2013-09-04 | 2015-10-27 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens system capable of interfacing with an external device |
US9592116B2 (en) * | 2013-09-17 | 2017-03-14 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus for ophthalmic devices including cycloidally oriented liquid crystal layers |
FR3011095B1 (en) * | 2013-09-26 | 2016-12-23 | Valeo Vision | ADAPTIVE OPTICAL FILTER FOR GLASSES OF GLASSES |
US9987808B2 (en) | 2013-11-22 | 2018-06-05 | Johnson & Johnson Vision Care, Inc. | Methods for formation of an ophthalmic lens with an insert utilizing voxel-based lithography techniques |
US9642525B2 (en) * | 2013-11-22 | 2017-05-09 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens with retinal vascularization monitoring system |
US9654674B1 (en) | 2013-12-20 | 2017-05-16 | Verily Life Sciences Llc | Image sensor with a plurality of light channels |
US9572522B2 (en) | 2013-12-20 | 2017-02-21 | Verily Life Sciences Llc | Tear fluid conductivity sensor |
US9366570B1 (en) | 2014-03-10 | 2016-06-14 | Verily Life Sciences Llc | Photodiode operable in photoconductive mode and photovoltaic mode |
US9184698B1 (en) | 2014-03-11 | 2015-11-10 | Google Inc. | Reference frequency from ambient light signal |
US9789655B1 (en) | 2014-03-14 | 2017-10-17 | Verily Life Sciences Llc | Methods for mold release of body-mountable devices including microelectronics |
TW201544085A (en) * | 2014-05-16 | 2015-12-01 | Univ Nat Chiao Tung | An artificial retinal prosthesis system and an artificial retinal chip |
US10381687B2 (en) | 2014-08-21 | 2019-08-13 | Johnson & Johnson Vision Care, Inc. | Methods of forming biocompatible rechargable energization elements for biomedical devices |
US9793536B2 (en) | 2014-08-21 | 2017-10-17 | Johnson & Johnson Vision Care, Inc. | Pellet form cathode for use in a biocompatible battery |
US9599842B2 (en) | 2014-08-21 | 2017-03-21 | Johnson & Johnson Vision Care, Inc. | Device and methods for sealing and encapsulation for biocompatible energization elements |
US9941547B2 (en) | 2014-08-21 | 2018-04-10 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes and cavity structures |
US9923177B2 (en) * | 2014-08-21 | 2018-03-20 | Johnson & Johnson Vision Care, Inc. | Biocompatibility of biomedical energization elements |
US10627651B2 (en) | 2014-08-21 | 2020-04-21 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers |
US9899700B2 (en) * | 2014-08-21 | 2018-02-20 | Johnson & Johnson Vision Care, Inc. | Methods to form biocompatible energization elements for biomedical devices comprising laminates and deposited separators |
US10361405B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Biomedical energization elements with polymer electrolytes |
US10361404B2 (en) | 2014-08-21 | 2019-07-23 | Johnson & Johnson Vision Care, Inc. | Anodes for use in biocompatible energization elements |
US9383593B2 (en) * | 2014-08-21 | 2016-07-05 | Johnson & Johnson Vision Care, Inc. | Methods to form biocompatible energization elements for biomedical devices comprising laminates and placed separators |
US9715130B2 (en) | 2014-08-21 | 2017-07-25 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form separators for biocompatible energization elements for biomedical devices |
CA2900271A1 (en) * | 2014-08-21 | 2016-02-21 | Johnson & Johnson Vision Care, Inc. | Components with multiple energization elements for biomedical devices |
US9907498B2 (en) * | 2014-09-04 | 2018-03-06 | Verily Life Sciences Llc | Channel formation |
RU2585010C1 (en) * | 2014-12-12 | 2016-05-27 | Антон Борисович Архипов | Plant for double-sided finishing surface of intraocular lenses |
US10345620B2 (en) | 2016-02-18 | 2019-07-09 | Johnson & Johnson Vision Care, Inc. | Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices |
US10488677B2 (en) * | 2016-03-03 | 2019-11-26 | Verily Life Sciences Llc | Electronics embedded in rigid gas permeable contact lenses |
CN106335149A (en) * | 2016-08-30 | 2017-01-18 | 镇江视伟光学有限公司 | Manufacturing method for high-definition UV400 prevention lens |
US10850461B2 (en) * | 2016-09-27 | 2020-12-01 | Coopervision International Holding Company, Lp | Method of manufacturing contact lenses |
CN106476187A (en) * | 2016-11-08 | 2017-03-08 | 镇江视伟光学有限公司 | A kind of manufacture method of uv blocking 400 eyeglass of high definition |
KR102437814B1 (en) | 2018-11-19 | 2022-08-29 | 이-비전 스마트 옵틱스, 아이엔씨. | Beam Steering Device |
US11550167B2 (en) * | 2018-12-11 | 2023-01-10 | Verily Life Sciences Llc | Ophthalmic device with blend zones and alignment sidewalls |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4075420A (en) | 1975-08-28 | 1978-02-21 | Burroughs Corporation | Cover layer for flexible circuits |
US5219497A (en) * | 1987-10-30 | 1993-06-15 | Innotech, Inc. | Method for manufacturing lenses using thin coatings |
ES2076216T3 (en) | 1988-11-02 | 1995-11-01 | British Tech Group | CASTING FOR CASTING AND PACKAGING OF CONTACT LENSES. |
US5573108A (en) | 1988-11-02 | 1996-11-12 | British Technology Group Ltd. | Disposable contact lens package |
JPH06165570A (en) | 1992-11-19 | 1994-06-10 | Nippon Densan Corp | Hybrid integrated circuit for dc motor |
IL113693A0 (en) * | 1994-06-10 | 1995-08-31 | Johnson & Johnson Vision Prod | Contact lens production line pallet system |
US6609041B1 (en) | 1999-05-05 | 2003-08-19 | Johnson & Johnson Vision Care, Inc. | Method and system for SKU tracking and changeover |
US6986579B2 (en) | 1999-07-02 | 2006-01-17 | E-Vision, Llc | Method of manufacturing an electro-active lens |
US6851805B2 (en) * | 1999-07-02 | 2005-02-08 | E-Vision, Llc | Stabilized electro-active contact lens |
WO2001040846A2 (en) | 1999-11-01 | 2001-06-07 | Praful Doshi | Tinted lenses and methods of manufacture |
US6880932B2 (en) * | 1999-11-01 | 2005-04-19 | Praful Doshi | Tinted lenses and methods of manufacture |
US6623669B1 (en) * | 2000-06-16 | 2003-09-23 | Rodenstock North America, Inc. | Method and apparatus for casting lenses |
US6811805B2 (en) | 2001-05-30 | 2004-11-02 | Novatis Ag | Method for applying a coating |
DK1947501T3 (en) | 2002-08-09 | 2012-08-06 | E Vision Llc | Electroactive contact lens system |
WO2004049927A1 (en) | 2002-12-03 | 2004-06-17 | Koninklijke Philips Electronics N.V. | Eye testing |
US7321795B2 (en) * | 2003-03-24 | 2008-01-22 | Les Bogdanowicz | Compositions for electric stimulation of the eye |
WO2005016617A1 (en) | 2003-08-19 | 2005-02-24 | Menicon Co., Ltd. | Process for producing contact lens with marking and contact lens with marking obtained thereby |
US7311398B2 (en) * | 2004-03-05 | 2007-12-25 | Koninklijke Philips Electronics N.V. | Variable focus lens |
GB0407240D0 (en) * | 2004-03-30 | 2004-05-05 | Koninkl Philips Electronics Nv | Controllable optical lens |
US7343504B2 (en) | 2004-06-30 | 2008-03-11 | Silicon Labs Cp, Inc. | Micro controller unit (MCU) with RTC |
NZ554830A (en) * | 2004-10-01 | 2010-10-29 | Univ Rutgers | Bismuth flouride based nanocomposites as electrode materials |
WO2006063836A1 (en) | 2004-12-17 | 2006-06-22 | Novartis Ag | Colored contact lenses for enhancing a wearer’s natural eye color |
US7500750B2 (en) * | 2005-05-24 | 2009-03-10 | Anton Sabeta | Method and system for tracking the wearable life of an ophthalmic product |
DE102005038542A1 (en) | 2005-08-16 | 2007-02-22 | Forschungszentrum Karlsruhe Gmbh | Artificial accommodation system |
TWI351415B (en) | 2006-02-08 | 2011-11-01 | Johnson & Johnson Vision Care | Facilitating release of silicone hydrogel ophthalm |
WO2007133197A1 (en) * | 2006-05-10 | 2007-11-22 | Nanospectra Biosciences, Inc. | Plasmon resonant based eye protection |
EP1897668A1 (en) | 2006-09-11 | 2008-03-12 | L&P Swiss Holding Company | Method and system for automatically feeding inserts to a mold and mold |
US20080099515A1 (en) | 2006-10-11 | 2008-05-01 | Nordson Corporation | Thin line conformal coating apparatus and method |
JP5100310B2 (en) | 2006-10-31 | 2012-12-19 | 株式会社半導体エネルギー研究所 | Semiconductor device |
EP2078263B1 (en) | 2006-10-31 | 2019-06-12 | Semiconductor Energy Laboratory Co, Ltd. | Semiconductor device |
AR064985A1 (en) | 2007-01-22 | 2009-05-06 | E Vision Llc | FLEXIBLE ELECTROACTIVE LENS |
TWI511869B (en) * | 2008-02-20 | 2015-12-11 | Johnson & Johnson Vision Care | Stimulating biomedical device |
US7931832B2 (en) * | 2008-03-31 | 2011-04-26 | Johnson & Johnson Vision Care, Inc. | Ophthalmic lens media insert |
US9375886B2 (en) | 2008-10-31 | 2016-06-28 | Johnson & Johnson Vision Care Inc. | Ophthalmic device with embedded microcontroller |
US9375885B2 (en) | 2008-10-31 | 2016-06-28 | Johnson & Johnson Vision Care, Inc. | Processor controlled ophthalmic device |
-
2009
- 2009-10-14 US US12/578,720 patent/US9375885B2/en active Active
- 2009-10-21 EP EP09797214.5A patent/EP2349699B1/en active Active
- 2009-10-21 KR KR1020117012367A patent/KR101678840B1/en not_active Expired - Fee Related
- 2009-10-21 CN CN200980153863.XA patent/CN102271900B/en active Active
- 2009-10-21 CA CA2741922A patent/CA2741922C/en active Active
- 2009-10-21 JP JP2011534621A patent/JP6067224B2/en active Active
- 2009-10-21 AU AU2009309034A patent/AU2009309034B2/en not_active Ceased
- 2009-10-21 RU RU2011121844/05A patent/RU2506163C2/en active
- 2009-10-21 SG SG2013080221A patent/SG195614A1/en unknown
- 2009-10-21 WO PCT/US2009/061494 patent/WO2010051203A1/en active Application Filing
- 2009-10-21 BR BRPI0919957-8A patent/BRPI0919957B1/en not_active IP Right Cessation
- 2009-10-30 TW TW098136787A patent/TWI516362B/en not_active IP Right Cessation
- 2009-10-30 AR ARP090104201A patent/AR074017A1/en not_active Application Discontinuation
-
2011
- 2011-04-28 IL IL212528A patent/IL212528A/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI612358B (en) * | 2013-03-15 | 2018-01-21 | 壯生和壯生視覺關懷公司 | Ophthalmic device and method for removably attaching a media insert to a hydrogel lens |
Also Published As
Publication number | Publication date |
---|---|
EP2349699A1 (en) | 2011-08-03 |
JP6067224B2 (en) | 2017-01-25 |
WO2010051203A1 (en) | 2010-05-06 |
US9375885B2 (en) | 2016-06-28 |
RU2011121844A (en) | 2012-12-10 |
CN102271900A (en) | 2011-12-07 |
BRPI0919957A2 (en) | 2016-02-16 |
BRPI0919957B1 (en) | 2020-12-29 |
AU2009309034B2 (en) | 2015-11-12 |
EP2349699B1 (en) | 2016-08-03 |
CA2741922A1 (en) | 2010-05-06 |
AR074017A1 (en) | 2010-12-15 |
CN102271900B (en) | 2018-04-06 |
KR101678840B1 (en) | 2016-11-23 |
US20100109175A1 (en) | 2010-05-06 |
TWI516362B (en) | 2016-01-11 |
RU2506163C2 (en) | 2014-02-10 |
KR20110091714A (en) | 2011-08-12 |
SG195614A1 (en) | 2013-12-30 |
CA2741922C (en) | 2017-01-03 |
JP2012507747A (en) | 2012-03-29 |
IL212528A (en) | 2017-04-30 |
IL212528A0 (en) | 2011-06-30 |
AU2009309034A1 (en) | 2010-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201029831A (en) | Processor controlled ophthalmic device | |
TWI579135B (en) | Variable focus eye lens | |
RU2519346C2 (en) | Method and device for moulding ophthalmic lens with built-in data microcontroller | |
TWI588561B (en) | Sealing and encapsulation in energized ophthalmic devices with annular inserts | |
TWI545367B (en) | A method of forming an ophthalmic lens comprising a conductive material | |
TWI516827B (en) | Nethod for forming an energized ophthalmic lens | |
RU2639785C2 (en) | Method and apparatus for hard insert encapsulation into contact lens for vision adjustment in patients with astigmatism | |
RU2677536C2 (en) | Fastening and encapsulation in powered ophthalmic devices with annular inserts | |
TWI631385B (en) | A method of manufacturing an ophthalmic device with stabilizing features | |
KR20110081225A (en) | How to form a powered ophthalmic device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |